These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 16322885)
21. Reproducibility of ductal lavage cytology and cellularity over a six month interval in high risk women. Patil DB; Lankes HA; Nayar R; Masood S; Bryk M; Hou N; Rademaker A; Khan SA Breast Cancer Res Treat; 2008 Nov; 112(2):327-33. PubMed ID: 18097749 [TBL] [Abstract][Full Text] [Related]
22. Atypia and Ki-67 expression from ductal lavage in women at different risk for breast cancer. Cazzaniga M; Severi G; Casadio C; Chiapparini L; Veronesi U; Decensi A Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1311-5. PubMed ID: 16835329 [TBL] [Abstract][Full Text] [Related]
23. Correlation of nipple aspiration and ductal lavage cytology with histopathologic findings for patients before scheduled breast biopsy examination. West KE; Wojcik EM; Dougherty TA; Siziopikou KP; Albain KS; Gabram SG Am J Surg; 2006 Jan; 191(1):57-60. PubMed ID: 16399107 [TBL] [Abstract][Full Text] [Related]
24. Ductal lavage of fluid-yielding and non-fluid-yielding ducts in BRCA1 and BRCA2 mutation carriers and other women at high inherited breast cancer risk. Kurian AW; Mills MA; Jaffee M; Sigal BM; Chun NM; Kingham KE; Collins LC; Nowels KW; Plevritis SK; Garber JE; Ford JM; Hartman AR Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1082-9. PubMed ID: 15894656 [TBL] [Abstract][Full Text] [Related]
25. Prospective multicenter trial to determine the feasibility of collection and predictive ability of breast fluid analysis in postmenopausal women receiving SERMs. Sauter ER; Ganz PA; Ehya H; Hewett JE; Schlatter L; Kliethermes B; Daly MB Breast; 2007 Oct; 16(5):489-94. PubMed ID: 17482465 [TBL] [Abstract][Full Text] [Related]
26. Retinoic acid receptor-beta2 promoter methylation in random periareolar fine needle aspiration. Bean GR; Scott V; Yee L; Ratliff-Daniel B; Troch MM; Seo P; Bowie ML; Marcom PK; Slade J; Kimler BF; Fabian CJ; Zalles CM; Broadwater G; Baker JC; Wilke LG; Seewaldt VL Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):790-8. PubMed ID: 15824145 [TBL] [Abstract][Full Text] [Related]
27. The role of ductal lavage in the management of women at high risk for breast carcinoma. Khan SA Curr Treat Options Oncol; 2004 Apr; 5(2):145-51. PubMed ID: 14990208 [TBL] [Abstract][Full Text] [Related]
28. Nipple aspirate fluid color is associated with breast cancer. Sauter ER; Winn JN; Dale PS; Wagner-Mann C Cancer Detect Prev; 2006; 30(4):322-8. PubMed ID: 16963197 [TBL] [Abstract][Full Text] [Related]
29. Fluorescence in situ hybridization of ductal lavage samples identifies malignant phenotypes from cytologically normal cells in women with breast cancer. Adduci KM; Annis CE; DeVries S; Chew KL; Boutin J; Magrane G; Ljung BM; Waldman FM; Esserman LJ Cancer; 2007 Jun; 111(3):185-91. PubMed ID: 17474121 [TBL] [Abstract][Full Text] [Related]
30. Molecular analysis of nipple fluid for breast cancer screening. Suijkerbuijk KP; van der Wall E; Vooijs M; van Diest PJ Pathobiology; 2008; 75(2):149-52. PubMed ID: 18544970 [TBL] [Abstract][Full Text] [Related]
31. Ductal approaches to assessment and management of women at high risk for developing breast cancer. Locke I; Mitchell G; Eeles R Breast Cancer Res; 2004; 6(2):75-81. PubMed ID: 14979910 [TBL] [Abstract][Full Text] [Related]
32. Ductal lavage in the screening of high-risk women. Kenney PJ; Ellison MC Curr Womens Health Rep; 2003 Apr; 3(2):151-5. PubMed ID: 12628085 [TBL] [Abstract][Full Text] [Related]
33. Leptin expression in breast nipple aspirate fluid (NAF) and serum is influenced by body mass index (BMI) but not by the presence of breast cancer. Sauter ER; Garofalo C; Hewett J; Hewett JE; Morelli C; Surmacz E Horm Metab Res; 2004 May; 36(5):336-40. PubMed ID: 15156414 [TBL] [Abstract][Full Text] [Related]
34. Technical enhancements to breast ductal lavage. Tondre J; Nejad M; Casano A; Mills D; Love S Ann Surg Oncol; 2008 Oct; 15(10):2734-8. PubMed ID: 18636293 [TBL] [Abstract][Full Text] [Related]
35. Atypia and DNA methylation in nipple duct lavage in relation to predicted breast cancer risk. Euhus DM; Bu D; Ashfaq R; Xie XJ; Bian A; Leitch AM; Lewis CM Cancer Epidemiol Biomarkers Prev; 2007 Sep; 16(9):1812-21. PubMed ID: 17855699 [TBL] [Abstract][Full Text] [Related]
37. Paired ductal lavage and fine-needle aspiration specimens from patients with breast carcinoma. Brogi E; Miller MJ; Casadio C; Ljung BM; Montgomery L Diagn Cytopathol; 2005 Dec; 33(6):370-5. PubMed ID: 16299749 [TBL] [Abstract][Full Text] [Related]
38. Ductal lavage for breast cancer risk assessment. Rivers A; Newman LA Surg Oncol Clin N Am; 2005 Jan; 14(1):45-68, vi. PubMed ID: 15541999 [TBL] [Abstract][Full Text] [Related]
39. Biological markers of risk in nipple aspirate fluid are associated with residual cancer and tumour size. Sauter ER; Ehya H; Babb J; Diamandis E; Daly M; Klein-Szanto A; Sigurdson E; Hoffman J; Malick J; Engstrom PF Br J Cancer; 1999 Dec; 81(7):1222-7. PubMed ID: 10584885 [TBL] [Abstract][Full Text] [Related]
40. Cytology of ductal lavage fluid of the breast. Ljung BM; Chew KL; Moore DH; King EB Diagn Cytopathol; 2004 Mar; 30(3):143-50. PubMed ID: 14986293 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]